Mitchell Mcleod Pugh & Williams Inc. Purchases 366 Shares of UnitedHealth Group Incorporated $UNH

Mitchell Mcleod Pugh & Williams Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,739 shares of the healthcare conglomerate’s stock after buying an additional 366 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $2,102,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in UNH. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. GAMMA Investing LLC boosted its position in UnitedHealth Group by 7.4% during the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock worth $8,295,000 after purchasing an additional 1,089 shares during the period. Exchange Traded Concepts LLC lifted its holdings in shares of UnitedHealth Group by 49.0% during the first quarter. Exchange Traded Concepts LLC now owns 2,827 shares of the healthcare conglomerate’s stock worth $1,481,000 after buying an additional 930 shares during the last quarter. Finally, 1900 Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the first quarter worth approximately $203,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $359.70 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a fifty day moving average price of $322.74 and a two-hundred day moving average price of $347.08. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market capitalization of $325.77 billion, a P/E ratio of 15.58, a P/E/G ratio of 2.32 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 earnings per share. The business’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. KeyCorp upped their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Wells Fargo & Company upped their price target on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Barclays upped their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, Bank of America upped their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $384.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.